专家文章 | 孙剑

搜索
登录

热心肠智库专家文章 | 孙剑

2023

CAVarious ambient air pollutants, residential green spaces, fibrosis 4 scores, genetic susceptibility, and risk of severe liver disease

EES, 10.1016/j.ecoenv.2023.115246

CANovel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures

J HEPATOL, 10.1016/j.jhep.2023.05.039

CAImpact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B

J MED VIROL, 10.1002/jmv.28501

2022

FACAThe changing epidemiology of liver diseases in Asia

Liver Int, 10.1111/liv.15354

CAHepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts

Front Immunol, 10.3389/fimmu.2022.868809

CA[Expert consensus on measurement and clinical application of serum HBV RNA in patients with chronic HBV infection]

Zhonghua ganzangbing zazhi, 10.3760/cma.j.cn501113-20220420-00214

CAProbability of HBsAg loss after nucleos(t)ide analogue withdrawal depends on HBV genotype and viral antigen levels

J HEPATOL, 10.1016/j.jhep.2022.04.022

CACirculating HBV RNA: From biology to clinical applications

Hepatology, 10.1002/hep.32479

CAAdvances in new antivirals for chronic hepatitis B

Chin Med J, 10.1097/CM9.0000000000001994

2021

CAAssociation of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy

JID, 10.1093/infdis/jiab597

CAMetabolic Defects of Peripheral T Cells in COVID-19 Patients

J Immun, 10.4049/jimmunol.2100068

CAMethodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patients

ANTIVIR RES, 10.1016/j.antiviral.2021.105037

CASingle-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia

Genomics, 10.1016/j.ygeno.2021.01.026

2020

CALetter to the Editor: Can the Ratio of Serum HBV RNA to DNA Reflect the Reverse-Transcription Efficiency of Viral pgRNA?

Hepatology, 10.1002/hep.31691